This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Immunization  • Infectious Diseases  • Bacterial Infections  • Pediatrics, Other  • Alert me on articles by topic

Arch Pediatr Adolesc Med. 2005;159:195-196.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Invasive pneumococcal disease (IPD) is an important cause of morbidity and mortality in young children. In 2000, a 7-valent pneumococcal conjugate vaccine (PCV7) was licensed and recommended for IPD prevention in children.¹ Subsequent decreases in IPD incidence in young children have been noted.^2-3 However, population-based data are lacking on the impact of PCV7 on early childhood mortality. We used vital records data to assess the effects of PCV7 on mortality in children younger than 2 years in the United States.

Methods

Invasive pneumococcal disease deaths in children younger than 2 years were identified using multiple cause–coded vital records data for the United States from 1995 to 2001.⁴ Invasive pneumococcal disease deaths were defined as any deaths for which the underlying cause of death or any of the contributory causes indicated pneumococcal meningitis or pneumococcal septicemia. Deaths coded with unspecified meningitis or septicemia were included if pneumococcal infection was also listed on . . . [Full Text of this Article]

Results

Comment

AUTHOR INFORMATION
Matthew D. Redelings, MPH; Frank Sorvillo, PhD; Paul Simon, MD, MPH; Laurene Mascola, MD, MPH